Private Equity

Updated:

Veg Capital

Veg Capital deploys early-stage capital into companies replacing animal products across food and materials from its UK base.

Veg Capital logo

Veg Capital

Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

United Kingdom

City

Loughborough

Corporate office

Loughborough, United Kingdom

Sector focus

AgriTech & FoodTechClimateTechHealthcare Services

Frequently asked questions

What is Veg Capital's investment thesis?

Veg Capital invests exclusively in early-stage companies developing replacements for animal-derived products. The thesis covers plant-based foods, cultivated meat, precision fermentation, and animal-free materials such as leather and biomedical testing models. The firm's mandate does not extend to general climate-tech or food-tech categories outside the protein-and-materials transition scope.

Does Veg Capital invest from a single pool of capital or multiple vehicles?

Public filings do not confirm the structure of Veg Capital's investment vehicle or vehicles. No fund prospectus, limited partnership agreement, or regulatory filing indicating a traditional closed-end fund structure is publicly available. The firm operates as a private equity manager deploying into early-stage rounds, but allocators should request direct clarification on whether capital flows through a single committed fund, a series of special-purpose vehicles, or a rolling capital model.

How does Veg Capital source its deals?

Deal sourcing mechanics are not publicly documented. Given the firm's narrow mandate within a relatively tight-knit alternative-protein ecosystem in Europe, sourcing likely relies on founder networks, sector-specific accelerators, and thematic research origination. The firm does not publish sourcing criteria, co-investor partnerships, or proprietary origination programs on its website.

What investment stage does Veg Capital typically enter?

Veg Capital targets seed and start-up stage companies. This means pre-revenue or early-commercialisation positions where the science risk around alternative proteins—such as cell-line development, bioreactor scaling, and sensory parity—remains a primary underwriting variable. The firm does not appear to participate in growth-stage or public-market alternative-protein positions.

Is Veg Capital connected to The Vegan Society or any other advocacy organization?

The Veg Capital name suggests thematic alignment with plant-based and animal-free principles, but no formal structural connection to The Vegan Society, any animal-welfare organization, or any other mission-driven entity is publicly confirmed. The firm does not publish its ownership structure or limited partner base, so the relationship between the investment manager and any non-profit or advocacy entity remains unverified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Loughborough Private Equity profiles